AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24807339
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (400 micrograms every 3 hours after 800 micrograms vaginal loading dose)
Trial: 20560409
Drug: Group training
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group training (90-min sessions, twice a week for 12 weeks)
Trial: 15315964
Drug: ABVD +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABVD + RT (6 cycles of doxorubicin, bleomycin, vinblastine, dacarbazine followed by radiation therapy)
Trial: 10903600
Drug: Beta-blockers (propranolol)
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers (propranolol)
Trial: 9291744
Drug: Topical lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical lidocaine adrenaline tetracaine (LAT gel)
Trial: 3518526
Drug: Cladosporium herbarum
RxNorm normalized name: CLADOSPORIUM HERBARUM
DrugBank: Cladosporium herbarum (DB10865)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cladosporium herbarum preparation
Trial: 30962230
Drug: Internet cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet cognitive behavioural therapy (iCBT) fixed-order stress management (intervention group B)
Trial: 21338801
Drug: bovine somatotropin
RxNorm normalized name: Bovine somatotropin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bovine somatotropin (bST) treatment
Trial: 10218362
Drug: Mupirocin ointment
RxNorm normalized name: Mupirocin Ointment
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin ointment (2 ml, three times a day for three days)
Trial: 2141743
Drug: Ibuprofen as
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen as a supplement to conservative treatment
Trial: 2141743
Drug: Placebo as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo as a supplement to conservative treatment
Trial: 158003
Drug: Powder face
RxNorm normalized name: TITANIUM DIOXIDE 0.212 kg in 1 kg / ZINC OXIDE 0.15 kg in 1 kg TOPICAL POWDER [Larkly SPF30 Mineral Powder Face Sunscreen]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Powder face mask with 1.19% clindamycin phosphate in 70% ethanol applied once daily for 5 days
Trial: 158003
Drug: Solution with
RxNorm normalized name: LVP solution with potassium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution with 1.19% clindamycin phosphate in 70% ethanol applied once daily for 5 days
Trial: 158003
Drug: Powder face
RxNorm normalized name: TITANIUM DIOXIDE 0.212 kg in 1 kg / ZINC OXIDE 0.15 kg in 1 kg TOPICAL POWDER [Larkly SPF30 Mineral Powder Face Sunscreen]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Powder face mask without clindamycin phosphate applied once daily for 5 days
Trial: 31350270
Drug: peficitinib 100
RxNorm normalized name: peficitinib
DrugBank: Peficitinib (DB11708)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: peficitinib 100 mg once daily
Trial: 31350270
Drug: peficitinib 150
RxNorm normalized name: peficitinib
DrugBank: Peficitinib (DB11708)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: peficitinib 150 mg once daily
Trial: 23504137
Drug: Multi‐modality adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi‐modality adjuvant therapy
Trial: 23504137
Drug: Single‐modality adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single‐modality adjuvant therapy
Trial: 21503263
Drug: Tiotropium (a
RxNorm normalized name: tiotropium (as bromide)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium (a once‐daily inhaled anticholinergic)
Trial: 19364166
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba extract (GBE) 240 mg x d(‐1)
Trial: 14657447
Drug: Semantic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semantic treatment
Trial: 14657447
Drug: Phonological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phonological treatment
Trial: 9988898
Drug: AMO 2
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AMO 2 x 1000 mg/day (group A)
Trial: 9988898
Drug: ACA 2
RxNorm normalized name: Rubraca 200mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACA 2 x 1250 mg/day (group B)
Trial: 9988898
Drug: OME +
RxNorm normalized name: Sudafed OM
DrugBank: Oxymetazoline (DB00935)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: OME + AZI treatment
Trial: 2718921
Drug: Diet providing
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet providing 1 g ascorbic acid/d
Trial: 2718921
Drug: Diet limiting
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet limiting ascorbic acid to about 20 mg/d
Trial: 25969531
Drug: 6 months
RxNorm normalized name: leuprolide 45 mg/6 months intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 months of antituberculosis therapy using intermittent directly observed therapy (DOTs)
Trial: 25969531
Drug: 9 months
RxNorm normalized name: treprostinil
DrugBank: Treprostinil (DB00374)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 9 months of antituberculosis therapy using intermittent directly observed therapy (DOTs)
Trial: 23342782
Drug: Medication (Valaciclovir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (Valaciclovir Hydrochlordide and vitamin B1)
Trial: 20891044
Drug: Cernilton (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cernilton (two doses, specific dosages not mentioned)
Trial: 15857084
Drug: CO2 laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CO2 laser treatment after hand instrumentation
Trial: 8562664
Drug: Acute intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute intravenous clomipramine infusion
Trial: 8562664
Drug: Chronic oral
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic oral clomipramine treatment
Trial: 8562664
Drug: Patients who
RxNorm normalized name: MAYZENT 0.25mg Tablet Starter Pack (For Patients Who Will Receive The 2mg Maintenance Dosage)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients who worsened after clomipramine infusion
Trial: 31585544
Drug: FENO group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FENO group (asthma treatment guided by FENO plus symptoms)
Trial: 31585544
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care group (asthma treatment guided by symptoms only)
Trial: 19397224
Drug: Antioxidant therapy
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant therapy (daily combination of vitamin E 800 IU, vitamin C 250 mg, vitamin B6 100 mg, vitamin B12 250 mcg, folic acid 10 mg) for 8 weeks
Trial: 16856571
Drug: Nicorandil (NCR)
RxNorm normalized name: nicorandil
DrugBank: Nicorandil (DB09220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil (NCR) administered intravenously (4 mg) via intracoronary injection (2 mg) or continuously (4 mg/h) in poor flow patients.
Trial: 16856571
Drug: Nicorandil (NCR)
RxNorm normalized name: nicorandil
DrugBank: Nicorandil (DB09220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil (NCR) administered in good flow patients.
Trial: 9251423
Drug: 1 gm
RxNorm normalized name: Ifex 1 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 gm P2AM single bolus dose at admission followed by placebo infusion over the next 4 days
Trial: 9251423
Drug: 12 gm
RxNorm normalized name: Carimune 12 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 gm P2AM as a continuous infusion over the next 4 days
Trial: 20495585
Drug: Intrathecal midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intrathecal midazolam (2 mg)
Trial: 1531383
Drug: Epidural methyl
RxNorm normalized name: methylal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural methyl prednisolone (80 mg)
Trial: 6088395
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g intravenous immunoglobulin divided into three doses per therapy course for infection prophylaxis (Group A)
Trial: 6088395
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Group B) receiving identical chemoradiotherapy without immunoglobulin therapy
Trial: 23891275
Drug: Metformin 1000mg
RxNorm normalized name: METFORMIN 1000MG/SITAGLIPTIN 50MG TAB
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin 1000mg daily
Trial: 16723884
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (loading 10 mg/kg followed by 30 mg/kg daily)
Trial: 16723884
Drug: Nimodipine (48
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimodipine (48 mg/d)
Trial: 8481256
Drug: Conventional postoperative
RxNorm normalized name: ENSURE SURGERY PERIOPERATIVE KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional postoperative therapy
Trial: 28206674
Drug: SCS-ON (Spinal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCS-ON (Spinal Cord Stimulation, 50 Hz, 210-μs pulse duration, 12 hours daily)
Trial: 25898052
Drug: Oral insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral insulin (67.5 mg)
Trial: 25898052
Drug: Oral insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral insulin (22.5 mg)
Trial: 25898052
Drug: Oral insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral insulin (7.5 mg)
Trial: 25898052
Drug: Oral insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral insulin (2.5 mg)
Trial: 22007909
Drug: 10% urea-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% urea-based lotion (Ureadin Rx 10)
Trial: 22007909
Drug: Glycerol-based emollient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycerol-based emollient cream (Dexeryl)
Trial: 16490584
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation (Sensibit)
Trial: 16490584
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation (Clarityne)
Trial: 12499977
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose antithrombin (AT group)
Trial: 12499977
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment alone (nonAT group)
Trial: 12832314
Drug: Repaglinide/metformin
RxNorm normalized name: repaglinide/metformin HCl 1 mg-500 mg ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repaglinide/metformin
Trial: 12832314
Drug: Nateglinide/metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nateglinide/metformin
Trial: 11234559
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of calcipotriol and diflucortolone valerate ointment
Trial: 11234559
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (calcipotriol and diflucortolone valerate)
Trial: 6491703
Drug: 5-fluorouracil (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-fluorouracil (15 mg/kg by rapid intravenous injection X 3) plus radiation (3,750 rad in 24 fractions)
Trial: 6491703
Drug: No surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No surgical adjuvant therapy
Trial: 6491703
Drug: Treatment refusal
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment refusal
Trial: 29862619
Drug: ipragliflozin 50
RxNorm normalized name: BEXAGLIFLOZIN
DrugBank: Bexagliflozin (DB12236)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ipragliflozin 50 mg/day
Trial: 25237981
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of AAB and ibuprofen
Trial: 20883560
Drug: ATG-Fresenius plus
RxNorm normalized name: ATG-Fresenius S
DrugBank: ATG-Fresenius S (DB05320)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATG-Fresenius plus reduced-dose tacrolimus monotherapy
Trial: 20883560
Drug: Standard-dose tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard-dose tacrolimus plus steroids
Trial: 16046455
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone administration (GH) 6 IU/day for 2 weeks
Trial: 12153969
Drug: Once-daily 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily 2.5 mg rhDNase
Trial: 12153969
Drug: Alternate-day 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternate-day 2.5 mg rhDNase
Trial: 12153969
Drug: Twice-daily 7%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-daily 7% HS
Trial: 12153969
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of daily rhDNase with alternate-day rhDNase and HS
Trial: 18328120
Drug: Losartan 100
RxNorm normalized name: LOSARTAN 100MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 100 mg/HCTZ 25 mg
Trial: 10915394
Drug: Enalapril 10
RxNorm normalized name: enalapril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 10 mg/HCTZ 25 mg
Trial: 7872282
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg q.i.d.
Trial: 7872282
Drug: Cisapride 20
RxNorm normalized name: cisapride 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 20 mg q.i.d.
Trial: 2370014
Drug: Cyclosporin 5-7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin 5-7.5 mg/kg/day
Trial: 6849742
Drug: Practolol 200
RxNorm normalized name: (±)-practolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Practolol 200 mg
Trial: 31332775
Drug: Single-injection Erector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-injection Erector Spinae Plane Block (ESPB)
Trial: 31332775
Drug: Multiple-injection Costotransverse
RxNorm normalized name: sodium acetate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multiple-injection Costotransverse Block (MICB)
Trial: 31332775
Drug: Single-injection Thoracic
RxNorm normalized name: Thoracol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-injection Thoracic Paravertebral Block (TPVB)
Trial: 31332775
Drug: Multiple-injection Thoracic
RxNorm normalized name: Thoracol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-injection Thoracic Paravertebral Block (TPVB)
Trial: 28452195
Drug: Serelaxin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serelaxin (30 µg/kg/day)
Trial: 18337551
Drug: Intravenous mesna
RxNorm normalized name: Mesna
DrugBank: Coenzyme M (DB09110)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous mesna 5 mg/kg thrice weekly before dialysis
Trial: 3234474
Drug: Fenoterol 2.5
RxNorm normalized name: fenoterol 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol 2.5 mg t.d.s.
Trial: 28741272
Drug: Intrathecal injection
RxNorm normalized name: BACLOFEN 50 ug in 1 mL INTRATHECAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal injection of 11.25 mg hyperbaric bupivacaine with morphine 150 µg and fentanyl 15 µg
Trial: 28741272
Drug: Intrathecal injection
RxNorm normalized name: BACLOFEN 50 ug in 1 mL INTRATHECAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal injection of 15 mg hyperbaric bupivacaine with morphine 150 µg and fentanyl 15 µg
Trial: 23349254
Drug: Biostimine (Aloe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biostimine (Aloe arborescens Mill. extract), 1 ampoule once daily for 4 weeks
Trial: 19650798
Drug: Rocuronium infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium infusion at CSM
Trial: 19650798
Drug: Rocuronium infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium infusion at APM
Trial: 14663908
Drug: Intratumoral chemotherapy
RxNorm normalized name: bimatoprost
DrugBank: Bimatoprost (DB00905)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intratumoral chemotherapy with cytostatic drugs and prednisolone during bronchofibroscopy
Trial: 8999375
Drug: Constant propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Constant propofol infusion of 200 micrograms/kg/min during the pre-bypass period and fentanyl boluses of 1 mg when required (PH Group)
Trial: 8999375
Drug: Variable propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Variable propofol infusion (from 43.09 to 22.42 micrograms/kg/min) during the pre-bypass period and a fixed infusion of 10.47 micrograms/kg/min during the post-bypass period (PL Group)
Trial: 8999375
Drug: 1% isoflurane
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% isoflurane administration throughout the intraoperative period (F Group)
Trial: 28850378
Drug: Vapocoolant spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vapocoolant spray (V)
Trial: 28850378
Drug: Placebo spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo spray (S)
Trial: 23311540
Drug: 8 gm
RxNorm normalized name: Cola 38 GM/30 ML Oral Syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 gm MgSO4 (two 4 gm doses q4H) (Group B, 8 patients)
Trial: 23311540
Drug: 12 gm
RxNorm normalized name: Carimune 12 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 gm MgSO4 (three 4 gm doses q4H) (Group C, 8 patients)
Trial: 23311540
Drug: 16 gm
RxNorm normalized name: magnesium citrate 16 GM Powder for Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 gm MgSO4 (four 4 gm doses q4H) (Group D, 8 patients)
Trial: 21711463
Drug: Glycolic acid
RxNorm normalized name: Glycolic Acid
DrugBank: Glycolic acid (DB03085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glycolic acid (reference resurfacing molecule)
Trial: 16886975
Drug: Levetiracetam (LEV)
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam (LEV) 4,000 mg over 15 min
Trial: 16886975
Drug: Levetiracetam (LEV)
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam (LEV) 2,500 mg over 5 min
Trial: 16886975
Drug: Levetiracetam (LEV)
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam (LEV) administered IV
Trial: 15617949
Drug: Blind group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blind group (active drug and placebo)
Trial: 15617949
Drug: Nonblind group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonblind group (active drug and no treatment)
Trial: 11020259
Drug: Bifidobacterium longum,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bifidobacterium longum, Lactobacillus acidophilus and oligofructose (c.1011 cfu of B. longum BB 536 and L. acidophilus NCFB 1748 and 15 g oligofructose daily)
Trial: 8246751
Drug: Theophylline slow-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline slow-release tablet
Trial: 7049013
Drug: Theophylline syrup
RxNorm normalized name: Theophylline Syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline syrup
Trial: 3898281
Drug: Thymopentin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymopentin (50 mg administered subcutaneously)
Trial: 24083754
Drug: Docetaxel and
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel and cyclophosphamide six-cycle therapy (TC6)
Trial: 21459680
Drug: Celecoxib 100
RxNorm normalized name: celecoxib 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 100 mg
Trial: 21459680
Drug: Celecoxib 50
RxNorm normalized name: celecoxib 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 50 mg
Trial: 21459680
Drug: Celecoxib 100
RxNorm normalized name: celecoxib 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 100 mg followed by 50 mg
Trial: 18366084
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment using the dynamic cooling device (DCD)
Trial: 9414975
Drug: Fedotozine 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fedotozine 30 mg three times daily
Trial: 8503552
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of allergen-antibody complexes (Group A)
Trial: 8503552
Drug: Lower doses
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower doses of allergen-antibody complexes (Group B)
Trial: 7612555
Drug: Intraoperative application
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative application of mitomycin C (0.1 mg/ml for 5 minutes)